Authors
Latest:
The American Rescue Plan Act of 2021: Pharmaceutical Industry ImpactAssessing the implications for the pharma industry of the America Rescue Plan Act of 2021, which provides nearly two trillion dollars in funding for various government programs, including many related to public health.
Latest:
Billing Codes for DTx Would Open the Floodgates for Behavioral Health EquityApproval of Medicare and Medicaid coverage for digital therapeutics represents next step in advancing care for mental health patients.
Latest:
Emergency Use Authorization: What We’ve Learned Bringing COVID-19 Therapies to MarketPandemic forces pharma companies to work faster and smarter to meet hard deadlines.
Latest:
As Pharma Continues to Adapt to AI, the POSA Standard will Need to Equally AdaptU.S. patent law will have to adapt to the use of AI in the life sciences industry.
Latest:
Transforming Healthcare Data to Precision MedicineA modern healthcare ecosystem involves various stakeholders and many forms of complex data. Collaborations and a range of advanced approaches are essential to providing more uniform and complete healthcare to patients.
Latest:
Empathy: The Foundation of Health LiteracyGoing beyond the words of healthcare communication.
Latest:
Not Just Another Tactic: Why Pharmaceutical Brands Need to Build a Strategy Around Point of Care MessagingPoint of care messaging offers unique advantages in pharmaceutical marketing and should be a high priority in brand strategy discussions.
Latest:
Partnering to Respond to a Possible Nuclear ThreatRecent explosion at Zaporizhzhia nuclear power plant in Ukraine shows how pharma industry can pull together and take action in the face of adversity.
Latest:
Delivery and Disruption: Navigating a Changing Care TerrainThe diversification of site-of-care delivery models is accelerating rapidly, creating new go-to-market implications for drug manufacturers—but also new opportunities to drive more fundamental innovation in engagement and access strategies.
Latest:
Staying the Course: Double Down on Launch AgilityIn today’s fragmented commercial environment, navigating a more complex set of challenges while adapting new approaches to product launch is critical for biopharma brand teams.
Latest:
China’s 2022 NRDL OutlookThe 2022 National Reimbursement Drug List will see more pressures for new inclusions on the one hand, and more certainties for renewals on the other. At the same time, the process is becoming more interactive and transparent.
Latest:
The Top 5 Golden Opportunities for Pharma RecruitmentPharma companies must revise their recruitment strategies in the wake of a skills shortage.
Latest:
What Every Pharma CEO Should Know About Unlocking Scientific Data PotentialWhen integrated into pharmaceutical enterprises, scientific data has the potential to drive organizational growth and innovation. Mikael Hagstroem, CEO at leading laboratory informatics provider LabVantage Solutions, discusses how technology partners add significant value to pharmaceutical R&D, in addition to manufacturing quality.
Latest:
The EU Regulations Catching US Pharma Companies Off GuardCompanies that understand the regulatory environment in Europe can keep their trials on budget and on schedule.
Latest:
NFTs: What This New Kid on the Blockchain Means for HealthcareThere has been a push to implement NFTs, or non-fungible tokens, across many verticals, but there is still much to learn about their potential uses in healthcare and its brands.
Latest:
The Real Value of AI in Healthcare? Strengthening the Doctor-Patient RelationshipWhy empowering both parties with the tools and data they need to make clinical decisions should be a top priority in the AI renaissance—to bolster patient care and improve health outcomes.
Latest:
Elevating ESG Message: Today’s Modern Investor is KeyHow pharma companies can make sure their corporate strategy in ESG is appealing to younger generations—and aligns with the issues this large segment of sustainability investors care about most.
Latest:
5 Signs You Need Digital Healthcare Marketing SupportHow far should your digital strategy reach? Daniel King and Simon Davies offer five signs that indicate you need better digital support.
Latest:
The C-Suite’s Frontline Workers in Digital ChangeHow the CIO role has transformed and strengthened against the backdrop of COVID-19.
Latest:
Case Study: A Drug Launch into COVID HeadwindsLessons to launch by during a pandemic—or otherwise.
Latest:
How to Navigate Global Regulatory Hurdles to Successfully Launch a Medical DeviceManufacturers must navigate complex regulatory landscapes, understand diverse cultural nuances, and prioritize patient access in each region.
Latest:
A Look Back: The Life Sciences Industry in 2023 and a View for 2024In the coming year, efficiency and automation will take center stage to maximize constrained resources but balancing sensible financial management with strategic investments will be vital.
Latest:
The Role of AI in Digital TherapeuticsAI-enabled digital therapeutics have helped give new meaning to the term personalized medicine by tailoring not just the treatment itself, but the way that treatment is managed to the individual characteristics of each patient.
Latest:
Bridging the Data GapHow interoperability and clean data can harness the power of big data in pharma.
Latest:
As the Life Sciences Industry Transforms, New Risks EmergeLife sciences companies are collaborating more with technology enterprises, universities, and other groups, which is changing the landscape of the industry.
Latest:
Why Pharmaceutical Manufacturers Must Navigate Muddy Waters of ESG RequirementsRise in demand for sustainable practices forces industry to be more proactive.
Latest:
Blockchain, COVID-19 and the Pharmaceutical Supply ChainHannah Schofield and Lavan Thasarathakumar discuss what blockchain is, how it could help improve pharmaceutical supply chains, and the COVID-19 vaccine supply chain in particular, and touches on where we are already seeing blockchain technology being used in this area.
Latest:
How to Optimize ERP: Insights from Galera and Nabriva Therapeutics*** Wednesday, February 3, 2021 at 1pm EST | 12pm CST | 10am PST*** Industry leading ERP & MRP Solutions for Pharma. Join our informative Webinar with AdaptaLogix, the fastest growing NetSuite & Oracle partner, to learn more about the solutions that have been developed to meet mid-market pharma’s unmet needs. ***On demand available after final airing until Feb. 3, 2022***
